Augusta University Medical Center — Augusta, Georgia

Public research footprint of Augusta University Medical Center, compiled from the ClinicalTrials.gov public registry.

256

Registered studies

120

Active

Recruiting now

100

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT05047172 — Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular… (Active Not Recruiting)
NCT06337318 — Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden… (Recruiting)
NCT05976763 — Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Augusta University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.